Back to Agenda
Pharmaceuticals and Medical Devices Agency (PMDA) Town Hall
Session Chair(s)
Nobumasa Nakashima
Health Policy Director, National Healthcare Policy Secretariat
Cabinet Office, Japan
Representatives from the Pharmaceuticals and Medical Devices Agency (PMDA) will explain its current services and the Japanese drug regulation, and answer your questions on PMDA’s future initiatives/challenges for faster review and better life cycle management of drugs.
Please come prepared with your questions for the PMDA Town Hall panel. You may submit questions and topics of interest in advance to annualmeetingprogram@diahome.org, and include “PMDA Town Hall” in the subject line.
Learning Objective : Discuss the current situation of PMDA and Japanese regulation; Communicate with PMDA senior officials on Japanese drug regulatory issues.
Speaker(s)
Future Plan of PMDA for the Next Five Years
Tatsuya Kondo, MD, PhD
SH Medical Excellence JAPAN, Japan
President
Introduction of the Third 5-Year Mid-Term Plan of PMDA
Masaru Hiraiwa
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Director, Office of Planning and Coordination
PMDA's Efforts in the Medical Area
Tetsuo Nagano, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Executive Director
Safety Measures: The Risk Management Plan in Japan
Hiroshi Yamamoto, MS
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Chief Safety Officer
Have an account?